Kistler-Tiffany Companies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $823K | Buy |
12,863
+548
| +4% | +$36.7K | 0.13% | 135 |
|
|
2023
Q1 | $854K | Buy |
12,315
+17
| +0.1% | +$1.2K | 0.16% | 104 |
|
|
2022
Q4 | $885K | Sell |
12,298
-58
| -0.5% | -$4.37K | 0.18% | 98 |
|
|
2022
Q3 | $878K | Sell |
12,356
-441
| -3% | -$32K | 0.2% | 89 |
|
|
2022
Q2 | $985K | Buy |
12,797
+19
| +0.1% | +$1.45K | 0.21% | 83 |
|
|
2022
Q1 | $933K | Sell |
12,778
-758
| -6% | -$50.9K | 0.18% | 97 |
|
|
2021
Q4 | $844K | Sell |
13,536
-3,352
| -20% | -$197K | 0.16% | 86 |
|
|
2021
Q3 | $999K | Sell |
16,888
-936
| -5% | -$61.6K | 0.23% | 73 |
|
|
2021
Q2 | $1.19M | Buy |
17,824
+5
| +0% | +$326 | 0.27% | 63 |
|
|
2021
Q1 | $1.13M | Buy |
17,819
+1,294
| +8% | +$80.5K | 0.29% | 62 |
|
|
2020
Q4 | $1.02M | Buy |
16,525
+609
| +4% | +$37.4K | 0.29% | 59 |
|
|
2020
Q3 | $960K | Sell |
15,916
-1,914
| -11% | -$115K | 0.31% | 55 |
|
|
2020
Q2 | $1.05M | Buy |
17,830
+3,268
| +22% | +$195K | 0.37% | 50 |
|
|
2020
Q1 | $935K | Hold |
14,562
| – | – | 0.33% | 53 |
|
|
2019
Q4 | $935K | Buy |
14,562
+2,766
| +23% | +$158K | 0.33% | 54 |
|
|
2019
Q3 | $598K | Buy |
11,796
+590
| +5% | +$27.7K | 0.23% | 64 |
|
|
2019
Q2 | $508K | Sell |
11,206
-845
| -7% | -$39.4K | 0.19% | 74 |
|
|
2019
Q1 | $575K | Buy |
12,051
+584
| +5% | +$29.1K | 0.24% | 64 |
|
|
2018
Q4 | $596K | Sell |
11,467
-1,220
| -10% | -$65.5K | 0.28% | 57 |
|
|
2018
Q3 | $788K | Sell |
12,687
-394
| -3% | -$23.4K | 0.33% | 52 |
|
|
2018
Q2 | $724K | Sell |
13,081
-1,629
| -11% | -$88K | 0.32% | 54 |
|
|
2018
Q1 | $930K | Sell |
14,710
-692
| -4% | -$44.5K | 0.38% | 51 |
|
|
2017
Q4 | $944K | Buy |
15,402
+172
| +1% | +$10.8K | 0.37% | 51 |
|
|
2017
Q3 | $971K | Buy |
15,230
+1,987
| +15% | +$116K | 0.41% | 48 |
|
|
2017
Q2 | $738K | Buy |
13,243
+1,569
| +13% | +$85.4K | 0.34% | 51 |
|
|
2017
Q1 | $635K | Buy |
11,674
+1,189
| +11% | +$65.2K | 0.3% | 53 |
|
|
2016
Q4 | $613K | Buy |
10,485
+572
| +6% | +$31.3K | 0.3% | 55 |
|
|
2016
Q3 | $534K | Buy |
9,913
+3,276
| +49% | +$210K | 0.26% | 61 |
|
|
2016
Q2 | $488K | Sell |
6,637
-326
| -5% | -$23K | 0.25% | 62 |
|
|
2016
Q1 | $445K | Sell |
6,963
-124
| -2% | -$7.82K | 0.25% | 66 |
|
|
2015
Q4 | $502K | Buy |
7,087
+428
| +6% | +$28.3K | 0.28% | 63 |
|
|
2015
Q3 | $407K | Sell |
6,659
-95
| -1% | -$6.03K | 0.24% | 68 |
|
|
2015
Q2 | $449K | Buy |
6,754
+10
| +0.1% | +$659 | 0.27% | 66 |
|
|
2015
Q1 | $435K | Buy |
6,744
+413
| +7% | +$25.9K | 0.28% | 64 |
|
|
2014
Q4 | $374K | Buy |
6,331
+9
| +0.1% | +$508 | 0.24% | 70 |
|
|
2014
Q3 | $324K | Buy |
6,322
+10
| +0.2% | +$500 | 0.22% | 80 |
|
|
2014
Q2 | $306K | Buy |
6,312
+10
| +0.2% | +$493 | 0.22% | 76 |
|
|
2014
Q1 | $327K | Sell |
6,302
-760
| -11% | -$40.4K | 0.24% | 73 |
|
|
2013
Q4 | $375K | Sell |
7,062
-86
| -1% | -$4.38K | 0.28% | 67 |
|
|
2013
Q3 | $331K | Buy |
7,148
+16
| +0.2% | +$702 | 0.27% | 70 |
|
|
2013
Q2 | $319K | Buy |
+7,132
| New | +$310K | 0.27% | 66 |
|
Other funds holding BMY
Kistler-Tiffany Companies's BMY Position: Q2 2023 in Review
Kistler-Tiffany Companies increased its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2023, buying an estimated $36.7K and bringing the position to 12,863 shares worth $823K. The position accounts for 0.13% of the portfolio, ranked #135.
Kistler-Tiffany Companies first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.19M in Q2 2021. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Kistler-Tiffany Companies held 12,863 shares of Bristol-Myers Squibb worth $823K as of Q2 2023.
- Kistler-Tiffany Companies bought 548 Bristol-Myers Squibb shares in Q2 2023, an estimated $36.7K.
- Bristol-Myers Squibb made up 0.13% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #135 holding.
- Kistler-Tiffany Companies first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's Bristol-Myers Squibb position peaked at $1.19M in Q2 2021.
- 2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.